Assignee
ALLIGATOR BIOSCIENCE AB
SE·26 granted patents·13 pending applications·77 citations·filing 2000–2023
Top patents by PatentIndex Score
39 records- 0191US11873348B2PeptidesALLIGATOR BIOSCIENCE AB·Filed 2022·Granted Jan 16, 2024·4 cites·7 claims
- 0291US11535678B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2017·Granted Dec 27, 2022·8 cites·18 claims
- 0390US10689454B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2019·Granted Jun 23, 2020·4 cites·17 claims
- 0488US10414815B2scFV antibody libraryALLIGATOR BIOSCIENCE AB·Filed 2015·Granted Sep 17, 2019·9 cites·7 claims
- 0586US7282334B2Method for in vitro molecular evolution of protein functionALLIGATOR BIOSCIENCE AB·Filed 2005·Granted Oct 16, 2007·6 cites·7 claims
- 0685US6958213B2Method for in vitro molecular evolution of protein functionALLIGATOR BIOSCIENCE AB·Filed 2000·Granted Oct 25, 2005·11 cites·7 claims
- 0782US7563578B2Method for in vitro molecular evolution of protein functionALLIGATOR BIOSCIENCE AB·Filed 2007·Granted Jul 21, 2009·3 cites·6 claims
- 0880US12570753B2Combination therapies with anti CD40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2023·Granted Mar 10, 2026·0 cites·17 claims
- 0980US11008396B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2016·Granted May 18, 2021·2 cites·10 claims
- 1079US7388078B2Nucleic acids encoding polypeptides having chips activityALLIGATOR BIOSCIENCE AB·Filed 2006·Granted Jun 17, 2008·5 cites·5 claims
- 1178US12509526B2Anti-CD137 antibodies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 1278US7153655B2Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequenceALLIGATOR BIOSCIENCE AB·Filed 2002·Granted Dec 26, 2006·10 cites·35 claims
- 1376US7816085B2Method for in vitro molecular evolution of protein functionALLIGATOR BIOSCIENCE AB·Filed 2009·Granted Oct 19, 2010·1 cites·6 claims
- 1475US12448465B2PeptidesALLIGATOR BIOSCIENCE AB·Filed 2023·Granted Oct 21, 2025·0 cites·14 claims
- 1573US7081513B2Nucleic acids encoding (poly) peptides having chips activityALLIGATOR BIOSCIENCE AB·Filed 2001·Granted Jul 25, 2006·8 cites·2 claims
- 1672US11780928B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Oct 10, 2023·0 cites·15 claims
- 1767US7662551B2Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide moleculesALLIGATOR BIOSCIENCE AB·Filed 2002·Granted Feb 16, 2010·2 cites·13 claims
- 1867US7262012B2Method for in vitro molecular evolution of protein function using varied exonuclease digestion in two polynucleotide populationsALLIGATOR BIOSCIENCE AB·Filed 2003·Granted Aug 28, 2007·3 cites·29 claims
- 1966US12173082B2Bispecific polypeptides against CD137ALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Dec 24, 2024·0 cites·17 claims
- 2066US10577425B2Anti-CD40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2014·Granted Mar 3, 2020·1 cites·8 claims
- 2166US2021403589A1Combination therapies with anti cd40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2021·Application pending·0 cites
- 2265US10774150B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2020·Granted Sep 15, 2020·0 cites·12 claims
- 2358US2026055200A1Combination therapiesALLIGATOR BIOSCIENCE AB·Filed 2023·Application pending·0 cites
- 2458US2024287199A1Novel combination therapies and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2022·Application pending·0 cites
- 2557US12415862B2Methods and compositionsALLIGATOR BIOSCIENCE AB·Filed 2021·Granted Sep 16, 2025·0 cites·20 claims
- 2654US11149090B2Combination therapies with anti CD40 antibodiesALLIGATOR BIOSCIENCE AB·Filed 2015·Granted Oct 19, 2021·0 cites·16 claims
- 2753US10640567B2Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cellsALLIGATOR BIOSCIENCE AB·Filed 2017·Granted May 5, 2020·0 cites·20 claims
- 2852US9834589B2CD86 variants with improved affinity for CTLA-4ALLIGATOR BIOSCIENCE AB·Filed 2014·Granted Dec 5, 2017·0 cites·6 claims
- 2950US2008242605A1Chemotaxis-inhibiting protein of staphylococcus (chips) and its useALLIGATOR BIOSCIENCE AB·Filed 2007·Application pending·0 cites
- 3047US2022073635A1Novel polypeptidesALLIGATOR BIOSCIENCE AB·Filed 2019·Application pending·0 cites
- 3147US2022064325A1Novel polypeptidesALLIGATOR BIOSCIENCE AB·Filed 2019·Application pending·0 cites
- 3245US2005143307A1Chemotaxis-inhibiting protein of staphyloccocus (CHIPS) and its useALLIGATOR BIOSCIENCE AB·Filed 2005·Application pending·0 cites
- 3343US2019169308A1Novel bispecific polypeptides against cd137ALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 3443US2017304437A1Bispecific molecules capable of specifically binding to both ctla-4 and cd40ALLIGATOR BIOSCIENCE AB·Filed 2014·Application pending·0 cites
- 3542US2020048358A1Bispecific antibody against ox40 and ctla-4ALLIGATOR BIOSCIENCE AB·Filed 2018·Application pending·0 cites
- 3640US12570759B2PolypeptidesALLIGATOR BIOSCIENCE AB·Filed 2019·Granted Mar 10, 2026·0 cites·14 claims
- 3739US2015368318A1Mutants of interleukin-1 receptor antagonist and uses thereofALLIGATOR BIOSCIENCE AB·Filed 2015·Application pending·0 cites
- 3838US2019161555A1Bispecific Antibodies Directed Against OX40 and a Tumor-Associated AntigenALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
- 3937US2019309084A1Bispecific Polypeptides to GITR and CTLA-4ALLIGATOR BIOSCIENCE AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALLIGATOR BIOSCIENCE AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →